All of the results taken together at the time led to the interpretation that tolyporphin A was a potent substrate for binding to P-glycoprotein, blocking cellular efflux pump activity, and thereby reversing multidrug resistance of cancer cell lines. The gene discussed is ABCB1; the disease is cancer.